Trifecta Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$452 | – | 483 |
|
|
2025
Q1 | $452 | Hold |
3
| – | – | ﹤0.01% | 409 |
|
|
2024
Q4 | $554 | Hold |
3
| – | – | ﹤0.01% | 398 |
|
|
2024
Q3 | $591 | Hold |
3
| – | – | ﹤0.01% | 400 |
|
|
2024
Q2 | $620 | Hold |
3
| – | – | ﹤0.01% | 404 |
|
|
2024
Q1 | $813 | Hold |
3
| – | – | ﹤0.01% | 387 |
|
|
2023
Q4 | $710 | Hold |
3
| – | – | ﹤0.01% | 421 |
|
|
2023
Q3 | $588 | Hold |
3
| – | – | ﹤0.01% | 412 |
|
|
2023
Q2 | $631 | Hold |
3
| – | – | ﹤0.01% | 406 |
|
|
2023
Q1 | $606 | Hold |
3
| – | – | ﹤0.01% | 410 |
|
|
2022
Q4 | $654 | Buy |
+3
| New | +$654 | ﹤0.01% | 409 |
|